Stockreport

Design Therapeutics to Participate in Leerink’s Global Healthcare Conference

Design Therapeutics, Inc.  (DSGN) 
PDF CARLSBAD, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious [Read more]